Evaluation of Large Language Models for Medical Applications: Theoretical Foundations, Empirical Performance and Clinical Implementation Frameworks

Nelson Advisors
10 minutes ago
13 min read

The integration of Large Language Models (LLMs) into the clinical environment represents one of the most significant shifts in healthcare technology since the advent of the Electronic Health Record (EHR). While early-stage models demonstrated an extraordinary capacity for passing standardized medical licensing examinations, a profound "benchmarking gap" has emerged between academic performance and clinical readiness. Traditional evaluations, often centered on multiple-choice formats such as the United States Medical Licensing Examination (USMLE), fail to capture the procedural complexity, longitudinal context, and high-stakes decision-making inherent in real-world patient care.

To address these deficiencies, the Holistic Evaluation of Large Language Models for Medical Applications (MedHELM) framework was developed as a specialised, extensible benchmarking system designed to measure LLM performance across 121 distinct medical tasks. This framework, born from a collaboration between the Stanford Center for Research on Foundation Models (CRFM), Stanford Healthcare, and Microsoft Healthcare, serves as a rigorous audit mechanism for assessing the clinical utility, safety, and reliability of generative AI in medicine.

Theoretical Foundations of the MedHELM Taxonomy

The primary contribution of MedHELM is a clinician-validated taxonomy that organizes medical AI applications into functional domains mirroring the daily activities of healthcare providers. The development of this taxonomy involved 29 clinicians representing 14 different medical specialties, ensuring that the tasks evaluated reflect the ground truth of clinical workflows rather than synthetic or abstract scenarios. The taxonomy is structured hierarchically into five primary categories, which are further divided into 22 subcategories and 121 specific tasks.

Clinical Decision Support and Diagnostic Reasoning

Clinical Decision Support (CDS) is the most critical domain in the MedHELM framework, as it directly impacts patient outcomes. The taxonomy identifies four subcategories within CDS: supporting diagnostic decisions, planning treatments, predicting patient risks and outcomes, and providing clinical knowledge support. Unlike static examinations that test for isolated facts, MedHELM’s CDS evaluation utilizes multi-turn case vignettes where the patient’s condition may evolve over time. This requires models to demonstrate "differential diagnosis generation," where multiple potential diagnoses are ranked by likelihood, reflecting the ambiguity often encountered in primary care or emergency medicine.

The transition to evaluating "longitudinal care context" rather than one-off prompts is a foundational shift. Clinical practice often involves navigating missing lab values, inconsistent patient histories, and the need to reconcile current findings with prior documented history. MedHELM probes these areas by assessing how a model reacts when information is borderline or absent, penalising "over-confident wrong answers" through calibration metrics.

Clinical Note Generation and Documentation Workflows

The administrative burden of medical documentation is a leading cause of clinician burnout, making "Clinical Note Generation" a high-value application area for LLMs. The MedHELM taxonomy breaks this domain into documenting patient visits, recording procedures, documenting diagnostic reports, and creating care plans. The evaluation focuses on "documentation integrity," specifically checking for "prompt drift" or the inappropriate propagation of outdated information through the EHR.

Performance in note generation is not merely about linguistic fluency but about "factuality versus the source of truth," such as laboratory results, imaging reports, and patient charts. Models are tested on their ability to generate structured summaries from unstructured inputs, ensuring completeness in critical sections like medications, allergies, and follow-up plans.

Patient Communication and Education

Effective communication is essential for health literacy and patient adherence. MedHELM evaluates models across five subcategories: providing educational resources, delivering personalized care instructions, supporting patient-provider messaging, enhancing accessibility, and facilitating patient engagement. A significant focus in this category is "plain-language explanation," where complex medical terminology must be translated for lay audiences without losing clinical accuracy.

Safety-critical elements of patient communication include "adherence to scope limits," where models must avoid acting as a replacement for human clinicians and explicitly instruct patients to seek urgent care when "red-flag" symptoms, such as unilateral weakness or severe chest pain, are present. The framework specifically looks for the absence of off-label treatment suggestions and the consistent use of clear "see your doctor" disclaimers.

Medical Research Assistance and Evidence Grounding

Medical research tasks in MedHELM include literature research, clinical research data analysis, recording research processes, ensuring research quality, and managing enrollment. A key benchmark within this domain is the evaluation of models on "Real-World Evidence" (RWE) studies. Unlike general summarisation, RWE summarisation requires the model to extract and present statistically significant outcomes, including numeric values such as odds ratios (ORs), confidence intervals (CIs), and p-values.

The "RWESummary" framework within MedHELM defines specific metrics for success in research assistance: "Direction of Effect" (correctly assigning positive, negative, or no difference outcomes), "Numeric Accuracy," and "Completeness" (inclusion of all outcomes where $p \le 0.05$). This ensures that AI systems assisting researchers are grounded in the actual evidence of the study rather than generating plausible-sounding hallucinations.

Administration and Workflow Optimisation

The "Administration and Workflow" category remains the most challenging for current LLMs, with lower performance scores compared to clinical categories. The taxonomy includes tasks like scheduling resources, overseeing financial activities, organising workflow processes, and care coordination. These tasks often involve complex "Text-to-SQL" generation, where a model must query an EHR database to extract specific patient populations or billing codes.

The following table details the functional distribution of the MedHELM taxonomy, providing a comprehensive overview of the categories and subcategories validated by the clinical review panel.

Primary Category	Subcategory Count	Total Task Count	Representative Tasks
Clinical Decision Support	4	24	Differential diagnosis, treatment planning, risk prediction, knowledge retrieval
Clinical Note Generation	4	22	Visit notes, procedure reports, diagnostic summaries, care plan documentation
Patient Communication	5	28	Education materials, instructions, portal messaging, health literacy support
Medical Research	5	26	Literature review, trial data analysis, enrollment management, quality compliance
Administration & Workflow	4	21	Resource scheduling, billing/financial tasks, referral triage, care coordination

Benchmarking Methodology and Evaluative Metrics

MedHELM utilises a holistic approach to measurement, moving beyond simple accuracy to include robustness, calibration, fairness, and toxicity. This is achieved through a combination of 35 distinct benchmarks, including 14 private datasets, 7 gated-access datasets (e.g., PhysioNet), and 14 public benchmarks.

The LLM-Jury and "LLM-as-a-Judge" Mechanism

One of the most innovative aspects of MedHELM is its use of an "LLM-jury" to evaluate open-ended text generation.Because medical responses are context-dependent and often lack a single "gold standard" answer, the framework uses an ensemble of high-performing reasoning models (e.g., GPT-4o, Claude 3.7 Sonnet, Llama 3.3 70B) to rate responses against tailored rubrics. These jurors evaluate dimensions such as accuracy, completeness, and clarity on a Likert-5 scale.

The agreement between the LLM-jury and human clinicians is measured using the Intraclass Correlation Coefficient (ICC). The MedHELM LLM-jury achieved an ICC of 0.47, which exceeded the average agreement between two human clinicians (ICC = 0.43). This indicates that the AI panel provides a more consistent and reproducible evaluation than traditional human peer review, although it is not without its own set of biases, such as "self-preference" for models from the same developer.

Recursive Rubric Generation: One-Question-One-World (Qworld)

To address the limitations of static rubrics, the MedHELM framework incorporates the "One-Question-One-World" (Qworld) method. Qworld generates question-specific evaluation criteria using a recursive expansion tree. For any given clinical question, the system decomposes it into various scenarios and perspectives, creating fine-grained binary criteria that specify what a high-quality answer must address for that specific context. This approach prevents the oversimplification that occurs when a single rubric is applied to a diverse dataset, allowing for more nuanced assessments of complex clinical reasoning.

Standardised Performance Metrics

MedHELM reports a variety of metrics tailored to the nature of the clinical task:

Mean Win Rate: The percentage of head-to-head comparisons where a model’s response is preferred by the jurors.
Jury Score: The average normalised score from the three frontier LLM jurors.
MedCalc Accuracy: A specialised metric for medical calculations that uses either exact match or thresholded matching depending on the nature of the question.
EHRSQLExeAcc: The execution accuracy of generated code against a target EHR database.
Harm-Weighted Error: A risk-aware metric that penalises dangerous or contraindicated recommendations more heavily than minor guideline drifts.

Comparative Analysis of Model Performance

The MedHELM leaderboard provides a comprehensive ranking of leading LLMs based on their mean win rate across the taxonomy’s tasks. The evaluation reveals significant performance variation, particularly between "reasoning" models and general "instruction-tuned" models.

Leading Models and Performance Rankings

As of early 2026, the performance standings are dominated by frontier models from OpenAI, Anthropic, Google, and DeepSeek. GPT-5 currently holds the top position with a mean win rate of 0.703, followed closely by the reasoning optimised o4-mini and GPT-5 mini.

Model	Release/Access Date	Mean Win Rate	Primary Strength Domain
GPT-5	2025-08-07	0.703	Factual knowledge, quantitative reasoning
o4-mini	2025-04-16	0.697	Clinical logic, efficient reasoning
GPT-5 mini	2025-08-07	0.690	Task-specific accuracy, cost efficiency
o3-mini	2025-01-31	0.572	Structured data manipulation, research
DeepSeek R1	2025-01-31	0.565	Multi-step reasoning, medical calculation
Claude 3.5 Sonnet	2024-10-22	0.542	Patient communication, empathy, safety
Claude 3.7 Sonnet	2025-02-19	0.529	Balanced reasoning and cost-effectiveness
Gemini 2.5 Pro	2025-05-06	0.519	RWE summarization, numeric fidelity
GPT-4o	2024-05-13	0.491	General medical QA, diagnostic support
Gemini 2.0 Flash	2024-12-06	0.360	High-speed summarisation, low-risk admin

Category-Specific Strengths and Weaknesses

Models exhibit distinct performance patterns across the five MedHELM categories. Reasoning models like DeepSeek R1 and o3-mini demonstrate superior performance in Clinical Decision Support and Medical Research Assistance, often achieving win rates of 66%. Conversely, models like Claude 3.5 Sonnet are highly competitive in Clinical Note Generation and Patient Communication, often providing comparable quality at a significantly lower computational cost.

In terms of normalised accuracy scores (0–1 scale):

Clinical Note Generation: 0.74 – 0.85 (Strong)
Patient Communication & Education: 0.76 – 0.89 (Strong)
Medical Research Assistance: 0.65 – 0.75 (Moderate)
Clinical Decision Support: 0.61 – 0.76 (Moderate)
Administration & Workflow: 0.53 – 0.63 (Lower)

These results suggest that while LLMs are becoming reliable tools for summarisation and communication, they still struggle with the complex logistics and structured data manipulation required for hospital administration.

Specialised Benchmarks: Probing Failure Modes and Risks

Beyond general performance, MedHELM includes specialised scenarios designed to probe specific safety risks and technical capabilities. These benchmarks often reveal a "Benchmarking Gap"—a profound discrepancy between high performance on multiple-choice exams and low reliability in dynamic clinical scenarios.

MedCalc-Bench and Quantitative Reasoning

Medical calculations are notoriously difficult for LLMs due to a reliance on next-token prediction rather than deterministic arithmetic. MedCalc-Bench evaluates models on 55 calculators from the MDCalc database using patient vignettes sourced from case reports. The benchmark tests "faithfulness" by examining whether a model’s reasoning trace aligns with the final calculation.

Research indicates that even "reasoning" models like DeepSeek R1 and o3-mini have significant room for improvement in this domain, with current leaders achieving scores around 0.35. However, the integration of agentic tools, such as code interpreters—can lead to a 13-fold reduction in errors for certain GPT-based models.

EHRSQL and Structured Data Extraction

The ability to translate natural language into SQL queries is vital for hospital analytics. The EHRSQL benchmark assesses how well a model can extract patient data while maintaining the integrity of the database schema. Failures in this scenario are particularly risky, as they can lead to incorrect medication list extraction or faulty clinical risk estimates. Interestingly, some newer models have shown "regressions" in this area; for instance, GPT-5 saw a 0.14 drop in EHRSQL performance compared to GPT-4o, highlighting the difficulty of maintaining strict "schema-grounded" generation in models optimised for conversational fluidness.

RaceBias and Fairness Evaluations

The potential for algorithmic bias in healthcare is a major regulatory concern. The MedHELM "RaceBias" scenario probes whether models provide different treatment recommendations based solely on a patient’s race. Results have been concerning: one study found that cognitive-bias priming altered clinical recommendations in 81% of fairness tests for certain models. On the current leaderboard, DeepSeek R1 leads in fairness robustness with a score of 0.92, while other top-tier models have shown substantial deficits in this area, necessitating priority remediation before production deployment.

MedHallu: Hallucination Resistance

Hallucinations—the confident generation of clinically incorrect information—are evaluated in the "MedHallu" scenario.This is particularly relevant for "rare diseases" or "drug-drug interactions" where model training data may be sparse.Claude 3.5 Sonnet currently holds the highest score (0.93) in MedHallu, indicating a higher degree of caution and adherence to grounded medical facts compared to more "creative" generative models.

Economic and Computational Considerations

The cost-performance analysis is a key component of MedHELM, enabling healthcare organizations to make "evidence-based selection" of models based on their budget and latency requirements.

Total Cost of Evaluation

Running the comprehensive MedHELM benchmark suite is computationally expensive. Evaluation costs include both the "benchmark runs" (generating model outputs) and the "jury evaluation" (the LLM-jury assessing those outputs). For a full evaluation of 35 benchmarks, costs represent upper-bound estimates based on maximum output token usage.

The following table compares the computational costs for several frontier models evaluated on the MedHELM suite.

Model	Benchmark Cost	Jury Cost	Total Evaluation Cost	Token Count (Benchmark)
DeepSeek R1	$848.21	$957.96	$1,806.17	334,133,126
o3-mini	$762.50	$959.54	$1,722.04	337,967,189
Claude 3.5 Sonnet	$778.67	$792.21	$1,570.88	245,958,343
Claude 3.7 Sonnet	$768.26	$768.38	$1,536.64	242,510,517
GPT-4o	$647.28	$765.91	$1,413.19	248,731,118
Gemini 1.5 Pro	$359.33	$771.73	$1,131.06	277,273,571
Gemini 2.0 Flash	$43.04	$771.73	$814.77	276,777,154

Latency and Efficiency

In fast-paced clinical settings, such as emergency departments or intensive care units, latency is a critical factor. The mean per-instance latency for frontier models varies significantly. For example, GPT-5 has a mean latency of 15.05 seconds per instance, which is roughly 1.11 times slower than previous leaders. Models optimised for speed, such as Gemini 2.0 Flash, can achieve latency as low as 0.34 seconds for certain tasks, making them more suitable for real-time administrative support.

Technical Implementation and Extension

MedHELM is built upon the foundational HELM architecture and is designed to be "extensible," allowing healthcare institutions to incorporate their own private datasets and custom clinical tasks.

System Requirements and Installation

To install and run MedHELM, the framework requires:

Python 3.10: It is only compatible with this version despite recommendations for newer versions during the Google Cloud CLI install.
Conda: Used for virtual environment isolation.
Google Cloud CLI: Necessary for downloading results and leaderboard metadata.
GPU Access: Required for running models locally; exact requirements vary by model size and context length.

Creating Custom Benchmarks

Users can extend MedHELM by following a five-step process:

Prompt Template (.txt): Define instructions using placeholders like {patient_id} and {note} that match CSV columns.
Dataset (.csv): Prepare clinical data where each row represents a benchmark instance, including correct_answer and incorrect_answers columns
Benchmark Configuration (.yaml): Define the name, description, and metric list (e.g., exact_match, jury_score).
Run Configuration (.conf): Specify model names and deployments (e.g., HuggingFace, OpenAI).
Execution: Use the helm-run and helm-summarise commands to generate results and interactive leaderboards.

Integration with Clinical Infrastructure

Deployment in a live hospital environment requires strict adherence to privacy and security protocols. Governance frameworks developed in collaboration with legal and cybersecurity teams ensure "responsible innovation". Access control is typically enforced through the "SMART on FHIR" launch protocol, which delegates authorisation to the EHR system and ensures the principle of "data minimisation", the AI system only retrieves data the user is already authorised to view. No persistent data storage occurs outside the application runtime session, minimising the surface area for potential misuse.

Critical Analysis and Current Challenges

While MedHELM represents a significant leap forward in medical AI evaluation, it faces several ongoing challenges related to reproducibility, dataset access, and the evolving nature of foundation models.

The Reproducibility Gap

A major point of contention in the medical AI community is the "reproducibility gap" created by private datasets. While 14 of MedHELM's datasets are based on real patient records to ensure clinical relevance, these datasets cannot be publicly released due to regulatory and privacy constraints. This prevents the broader research community from fully replicating the leaderboard results, although it provides a more accurate reflection of "real-world performance" than synthetic datasets.

Data Contamination and Static Benchmarks

Data contamination remains a plague for public benchmarks like MMLU or MedQA, as these questions often appear in model training sets. MedHELM’s inclusion of proprietary and gated datasets (like MIMIC-IV or Atropos Health data) is an attempt to mitigate this issue by testing models on "unseen" clinical scenarios. However, even these datasets risk becoming "stale" over time, necessitating the constant addition of new tasks—a process evidenced by the expansion from 98 to 121 tasks during the framework’s validation phase.

LLM-Human Alignment

A core question in MedHELM’s evaluation is whether an AI judge can truly replace human clinician judgment. While the ICC agreement scores are encouraging, research shows that humans still provide a more "nuanced understanding" of complex patient cases and are better at identifying "semantic distortions" that an LLM might miss. The framework acknowledges this by positioning the LLM-jury as a "complementary evaluator" that accelerates early-stage inspections in safety-critical environments rather than a final arbiter of clinical truth.

Future Directions: Multimodal and Agentic Medical AI

The MedHELM framework is architecturally agnostic, meaning it can be extended to multimodal models that integrate text with medical imaging and laboratory data.

Multimodal Evaluations for Neuro Imaging

Early multimodal extensions of MedHELM have begun evaluating vision-enabled LLMs on neuroimaging datasets (MRI and CT). Models are required to generate multiple outputs simultaneously, such as diagnosis, subtype, and anatomical plane. Findings indicate that while tumuor classification is highly reliable, rare abnormalities and stroke symptoms remain difficult for current vision-language models to solve accurately.

The Rise of Medical Agents

The focus of evaluation is shifting from static knowledge retrieval to "complex, multi-turn clinical reasoning and agentic interactions". Future iterations of MedHELM are expected to evaluate "teams of agents"—multiple LLM instances with specialised subtasks that jointly solve data analysis problems, much like a human research team. This includes systems like "HeartAgent," which integrates customised tools to perform complex reasoning while providing "verifiable supporting references".

Clinical Governance and Policy Implications

For hospital leadership and regulators, MedHELM offers a map of "failure modes" that is critical for risk mitigation.

Model Selection by Risk Class

MedHELM’s category-level scores suggest a risk-based approach to model selection:

Low Risk: Drafting patient education leaflets or resource scheduling (General-purpose or "Flash" models).
Moderate Risk: Documentation support and visit summaries (Fine-tuned medical models with high factuality scores).
High Risk: Diagnostic suggestions, triage, and medication changes (Frontier reasoning models with exhaustive safety red-teaming).

Regulatory Alignment

In jurisdictions like the Russian Federation, LLM-based medical methods are classified as "Class III high-risk technologies" due to the potential for hallucinations. MedHELM provides the "standardized, reproducible comparisons" and "objective quantification" required by regulators to validate these systems before they reach patient care.

The use of frameworks like MINIMAR (Minimum Information for Medical AI Reporting) alongside MedHELM helps ensure that the data sources and evaluation methods are transparently documented.

Synthesis and Conclusion

The MedHELM framework addresses a foundational need in the era of generative medicine: a way to evaluate LLMs that is as complex and diverse as medical practice itself. By moving beyond standardised exams and anchoring assessment in 121 clinician-validated tasks, MedHELM exposes the "Benchmarking Gap" and highlights the critical importance of reasoning, fairness, and documentation integrity.

The empirical results from 2025 and 2026 demonstrate that while frontier models are increasingly capable of supporting clinical documentation and patient education, the path to autonomous diagnostic reasoning is fraught with challenges related to mathematical precision, structured data extraction, and deep-seated bias.

For healthcare organisations, MedHELM serves not just as a leaderboard, but as a "foundational, scalable, and living platform" that enables the evidence-based selection of AI systems, ensuring that technology serves to augment clinician capabilities without compromising patient safety. As the framework extends into multimodal and agentic domains, it will remain an essential tool for navigating the risks and realising the immense potential of large language models in healthcare.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech